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Several investigators have demonstrated an increased resistance to the protozoal parasite 
Trypanosoma cruzi (the causative agent of Chagas' disease) in highly susceptible C3H mice 
when maintained at an environmental temperature of 36°C. This increased resistance is 
manifested as delay in onset of parasitemia, decreased parasitemia, decreased pathology, and 
increased longevity with eventual clearing of the parasite from the bloodstream. In addition, this 
enhanced resistance has been shown to be an immunologic phenomenon and not due to the direct 
effects of elevated temperature on the parasite itself. To ascertain the possible contributions of 
humoral vs. cellular immunity to the above phenomenon, the relative success of passive transfer 
of sera and adoptive transfer of whole spleen cells was evaluated. Parasitemias and mortality of 
donor mice maintained at 21°C or 36°C were monitored. The same parameters were monitored 
in infected recipient mice held at 21°C and either given sera or whole spleen cells, from the 
donors, in an attempt to transfer protective immunity. The results of this experiment indicate 
that 1) an environmental temperature of 36°C does reduce the course of infection with T. cruzi, 
2) the positive effects of elevated temperature can be transferred to naive mice through the 
administration of whole spleen cells from surviving mice, 3) the beneficial effects are magnified 
as demonstrated by negligible parasitemias and more rapid clearing of blood-form 
trypomastigotes in the recipients of whole spleen cells as compared with the original mice that 
survived infection at 36°C, and 4) the positive effects cannot be attributed to antibodies due to 
the failure of passive transfer to impart any protection beyond that noted in the controls. 
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Introduction 
Trypanosoma cruzi, the etiologic agent of American trypanosomiasis or Chagas' disease, is 
estimated to currently infect up to 18-20 million people in Latin America (W.H.O., 1991) with 
one fourth of the total population (90 million more individuals) at risk (W.H.O., 1994). 
Mortality resulting from T. cruzi infection is usually a consequence of chronic disease pathology 
involving the heart. "Chagas' disease is thought to be the single most common cause of 
congestive heart failure and sudden death in the world and the leading cause of death among 
young to middle age adults in endemic areas of Latin America" (Tarleton et al., 1997). T. cruzi 
is believed to have successfully parasitized the inhabitants of this region since antiquity. Recent 
molecular techniques have allowed researchers to positively identify the presence of T. cruzi in 
seven approximately 4000 year old mummies unearthed from the Atacama Desert of Peru 
(Fackelmann, 1997). The success of the parasite appears to be centered on the availability of a 
large range of invertebrate hosts residing in Latin America, coupled with an intermittent indolent 
stage of infection that can last for decades in the vertebrate host. 
Despite its medical importance, many aspects of T. cruzi infection have continued to evade 
investigators. Today it is still not agreed upon as to how this agent causes disease or how the 
parasite is able to avoid immune destruction. Because of it's elusiveness, preventative measures, 
diagnosis, and effective treatments are far less than adequate. A complete understanding of this 
parasite is most likely decades away. 
Taxonomy and morphology of the parasite 
Trypanosoma cruzi is a member of the Kingdom Protista, Phylum Sarcomastigophora, 
Subphylum Mastigophora, Order Kinetoplastida, Family Trypanosomatidea (Brener, 1992). It is 
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closely related to other flagellated protists such as Leishmania, Giardia, and Trichomonas. T. 
cruzi does not exist as a homogeneous population but rather as a numerous range of strains that 
cycle between domestic and sylvatic hosts including humans, insect vectors, and mammalian 
reservoirs of the parasite (Brener, 1992). It is thought that these different strains are capable of 
producing varying disease states, with differences in parasitemia levels, virulence, pathogenicity, 
sensitivity to drugs, and tissue trophisms (Brener, 1992). Thus the typing or grouping of T. cruzi 
strains has been the focus of extensive investigations. "The antigenic make-up of different 
populations has been studied by analysis of radio-iodinated cell surface membrane components 
and band distribution in SDS-Page gel electrophoresis as well as monoclonal antibodies" 
(Brener, 1992). Some strain-specific antigens have been detected, but a great deal of cross 
reactivity has been observed (Brener, 1992). Newer approaches to strain characterization are 
currently being performed at the molecular level, and surface membrane carbohydrate residues, 
specific lectins, and isoenzyme markers are being employed for taxonomic purposes (Brener, 
1992). 
The structure that seems to hold the most promise for both identification and detection of all 
strains of T. cruzi in stained blood samples is the kinetoplast. The kinetoplast represents a 
portion of the single complex mitochondrion of the cell and contains a huge compact mass of 
DNA arranged into maxicircles and minicircles (Brener, 1992). The kinetoplast-DNA contains 
approximately 20 to 25% of the total parasitic DNA (Brener, 1992). The maxicircles are thought 
to code for enzymes essential to the metabolism of the parasite (Brener, 1992). The exact 
function of the minicircles is still uncertain, but they have been shown to contain highly 
conserved sequences in all T. cruzi species (Brener, 1992). Probes specific for these conserved 
regions have been useful for detection (Brener, 1992). The minicircles also contain highly 
strain-specific variable regions, and specific probes may be useful for more precise identification 
(Brener, 1992). The kinetoplast also may serve as a future target for innovative 
chemotherapeutic approaches due to the observations that dyskinetoplastic forms of T. cruzi are 
unable to complete a normal life cycle (Brener, 1992). Naturally occurring "dyskinetoplastic" 
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stages have been identified in Trypanosoma equiperdium and evansi species; however, evidence 
thus far indicates that T. cruzi is kinetoplastic-DNA (k-DNA) dependent (Brener, 1992). 
T. cruzi possesses a single flagellum arising from a specialized invagination known as the 
flagellar pocket at the basal surface of the organism (Brener, 1992). The flagellar pocket is the 
apparent site of nutrient uptake from the external media via the process of pinocytosis (Brener, 
1992). " The cytosome, an invagination of the surface membrane, is another region in which 
incorporation of pinocytotic vesicles and larger particles occurs" (Brener, 1992). The structural 
integrity of the parasite is maintained by subpellicular microtubules which act as a cytoskeleton 
but also are involved in cellular differentiation and tissue migration within the vertebrate host 
(Brener, 1992). The above listed organelles appear to be trypanosomatid-specific. Other 
organelles that are present are typical eukaryotic structures such as endoplasmic reticulum, 
ribosomes, golgi complexes, and peroxisomes (Brener, 1992). Interestingly, the activity of 
enzymes such as catalase and oxidases within the peroxisome is much lower in T. cruzi than in 
other similar organisms (Brener, 1992). 
Life cycle 
T. cruzi exhibits three known life forms. The amastigote form is the spherical intracellular 
form, 1.5 to 4.0 (am in diameter, and is usually observed in clusters in infected mammalian cells 
(Wendel and Gonzaga, 1993). This form has been reported to have a very short flagellum 
(Burleigh and Andrews, 1995). Epimastigotes have a well developed flagellum and a 
juxtanuclear kinetoplast and are the form seen in the foregut of the invertebrate vector (Wendel 
and Gonzaga, 1993). The trypomastigote stage is usually C or U shaped and approximately 12 to 
20 Jim in diameter (Wendel and Gonzaga, 1993). Trypomastigotes are found in the blood stream 
and occasionally in the cerebral spinal fluid (CSF) or lymphatic fluid of the vertebrate host 
during the acute phase of infection (Wendel and Gonzaga, 1993). At the ultrastructure level, 
trypomastigotes have a surface coat three times thicker than epimastigotes with fewer 
intramembrane particles and differing plasma membrane characteristics (Burleigh and Andrews, 
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1995). Within the host, T. cruzi is an obligate intracellular pathogen because it must enter host 
cells in order to replicate (Burleigh and Andrews, 1995). 
The infective stage of T cruzi, the metacyclic trypomastigote, develops in the hindgut of the 
intermediate host, hematophagus insects belonging to the family Reduvidae (Wendel and 
Gonzaga, 1993). Due to development within the hindgut rather than the salivary glands of the 
insect vector, the parasite is classified as stercorarian (Bogitsh and Cheng, 1990). This mode of 
transmission involves fecal contamination into a bite wound or across mucous membranes or 
conjunctiva (Kirchhoff, 1993). However, transmission is easily achieved due to the existence of 
many species of Reduviid bugs that defecate immediately following the ingestion of a blood 
meal, thus placing feces containing infective forms near the feeding port (Bogitsh and Cheng, 
1990). Children have a tendency to rub their face and eyes when first awakening which also 
facilitates the transmission of the parasite (Bogitsh and Cheng, 1990). Reservoir hosts (all 
mammals) may become infected via ingestion of the infected bugs directly or by the ingestion of 
other infected reservoirs (Bogitsh and Cheng, 1990). Once the metacyclic trypomastigote stages 
have gained entrance into the mammalian host, local inflammatory cells such as macrophages 
and neutrophils attempt to internalize it (Bogitsh and Cheng, 1990). Undetected, the amastigote 
forms multiply via longitudinal binary fission (Bogitsh and Cheng, 1990). Transformation 
occurs again into the trypomastigote forms which are hematogenously dispersed throughout the 
entire body, and new distant cells are subject to becoming parasitized (Kirchhoff, 1993). " In 
this way, a cycle is established that alternates asynchronously between intracellular multiplying 
forms and nondividing but infective forms that circulate in the bloodstream" (Kirchhoff, 1993). 
Completion of the cycle occurs when the reduviid bug takes a blood meal from an infected 
host and ingests the infective trypomastigote form (Kirchhoff, 1993). Once the parasite reaches 
the foregut of the insect, transformation occurs into the reproductive epimastigote stage and 
division occurs again via binary fission (Bogitsh and Cheng, 1990). Ten days after ingestion, 
infective metacyclic trypomastigotes can be identified in the rectum of reduviid bugs (Bogitsh 
and Cheng, 1990). 
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Vector 
Invertebrate hematophagus bugs belonging to the Family Reduvidae, Subfamily Triatominae, 
are responsible for transmission of T. cruzi (Wendel and Gonzaga, 1993). These insects are 
commonly called kissing bugs (Bogitsh and Cheng, 1990). Over ninety species exist worldwide 
of which forty have adapted to human habitats and thirty are linked with Chagas' disease 
transmission (Wendel and Gonzaga, 1993). The insects are widely distributed geographically on 
the American continents from Utah to Argentina with a predominance of certain species in 
specific geographical zones (Wendel and Gonzaga, 1993). 
Modes of transmission 
The sylvatic cycle involves reduviid bugs dwelling in holes within the bark of trees, in caves, 
or under rocks, where they are in constant contact with numerous natural reservoirs (Wendel and 
Gonzaga, 1993). The domestic cycle is very prevalent due to man's encroachment into naturally 
endemic areas and the extreme poverty of the inhabitants (Wendel and Gonzaga, 1993). The 
typical dwellings, or "ranchos", in the "backlands" of Latin America are rudimentary at best. 
The walls, which are constructed of wattle or bamboo filled in with mud, are full of holes and 
cracks (Wendel and Gonzaga, 1993). Palm thatches, an ideal habitat for triatomes, are used for 
roofing (Wendel and Gonzaga, 1993). These huts are usually windowless (Wendel and Gonzaga, 
1993). One structure such as this can harbor hundreds to thousands of reduviid bugs (Wendel 
and Gonzaga, 1993). Families co-exist in such dwellings along with cats, dogs, rats, etc. 
(Wendel and Gonzaga, 1993). Any domestic animals a family may own are kept very near the 
dwelling and thus a reservoir is always at hand. Tiny villages of such dwellings in very poor 
areas with little medical care have allowed for the continued presence of the domestic cycle of 
T. cruzi for thousands of years. 
Although uncommon, transplacental transmission was first described by Chagas in 1909. 
Lactogenic transmission may also serve as a secondary route of infection since T. cruzi can be 
found in the breast milk of infected women (Wendel and Gonzaga, 1993). Blood transfusion and 
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organ donor associated transmission have been reported with the former being the second most 
prevalent mode of transmission in endemic areas (Wendel and Gonzaga, 1993). 
Pathology 
T. cruzi infection usually manifests as a triad of complexes. The first phase of infection is the 
acute form that typically develops one to three weeks post infection (Bogitsh and Cheng, 1990). 
This stage may be indolent and go unnoticed or it may present with the classic clinical signs of 
edema and erythema at the site of parasite entry (Kirchhoff, 1993). These outward signs 
correlate with the initial invasion and multiplication of the parasite within macrophages of the 
subcutaneous tissues. This swelling is commonly termed a "chagoma" (Bogitsh and Cheng, 
1990). If the initial site of entry is the conjunctiva of the eye, then a syndrome involving 
periorbital edema and conjunctivitis ensues, which is termed "Romana's sign" (Bogitsh and 
Cheng, 1990). During the acute phase the number of circulating blood-form trypomastigotes is 
at its highest. This stage is often accompanied by fever, headache, malaise, generalized 
lymphadenopathy, and hepatosplenomegaly (Kirchhoff, 1993). Acute trypanosomiasis is usually 
a mild illness with a case fatality rate of less than 5% (Kirchhoff, 1993). The fatalities are most 
numerous in very young children and are due either to the invasion of T. cruzi into myocardial 
cells causing severe myocarditis or into the central nervous system leading to 
meningoencephalitis (Kirchhoff, 1993). "The factors that determine the severity of the disease in 
the acute phase are uncertain, but likely to be involved are the virulence of different strains of T. 
cruzi, the general state of health of the individual, and possibly his genetic background" 
(Trischmann et al., 1978). Those that survive the acute illness will experience spontaneous 
resolution over the next four to six weeks, and a quiescent infection ensues for an undetermined 
length of time (Kirchhoff, 1993). Victims are either asymptomatic or suffer mild intermediate 
bouts similar to those seen with the acute infection and may experience subtle cardiac or 
gastrointestinal involvement (Kirchhoff, 1993). At these times of reactivation, low parasitemias 
often can be detected (Kirchhoff, 1993). This cycle enhances the domestic transmission of T. 
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cruzi as humans can act as a reservoir, thus producing the threat of transfusion and organ donor 
transmission. Many individuals remain in this indeterminate phase for life (Kirchhoff, 1993). 
Within this phase an immunity appears to be present that prevents subsequent re-infection by the 
same strain of T. cruzi, but does not always prevent the chronic phase from developing 
(Trischmann et al., 1978). An estimated 10 to 30% of infected people will develop chronic 
Chagas' disease years to decades after initial infection (Kirchhoff, 1993). Organs most 
commonly affected include the heart, the esophagus, and the colon (Kirchhoff, 1993). The 
damage to the esophagus and colon may result in a syndrome known as megadisease (Kirchhoff, 
1993). The pathology of megadisease is primarily associated with the loss of local denervation 
leading to flaccid paralysis of these very distendable organs. Clinical manifestations include 
dysphagia, regurgitation, aspiration, and severe constipation (Kirchhoff, 1993). The heart has 
the gross appearance of congestive heart failure with biventricular enlargement and consequent 
wall thinning (Kirchhoff, 1993). The situation is very conducive to the formation of aneurysms 
(Kirchhoff, 1993). Histologically, there is diffuse interstitial fibrosis and myocardial atrophy 
(Kirchhoff, 1993). Clinical signs are indistinguishable from chronic heart failure (Kirchhoff, 
1993). Thus Chagas' disease can develop silently and become incurable. 
Chronic Chagasic pathology 
"A number of mechanisms have been proposed to account for chronic Chagasic pathology 
including direct parasite-mediated tissue destruction, loss of nervous tissue function, 
intravascular platelet aggregation, and generation of an autoimmune reactivity" (Tarleton et al., 
1997). The presence of an anti-self immune response has been unquestionably demonstrated, but 
its role in disease development is still undetermined (Tarleton et al., 1997). Supporting evidence 
for an underlying autoimmune etiology is the observation of the scarcity of parasites in the 
chronically inflamed tissues and the existence of shared epitopes between the parasite and host 
heart and neuronal tissue (Reviewed in Tarleton et al., 1997). 
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Investigations performed by Ribeiro-dos-Santos et al. (1992) strongly supported an 
autoimmune basis for the observed pathology. In these experiments, mice that were chronically 
infected with T. cruzi vigorously rejected normal uninfected heterotopic neonatal heart 
transplants in comparison to normal mice receiving the same treatment. These results suggested 
that chronic status had induced some type of anti-heart response. Further investigation led to the 
conclusion that the major effector cell in this response was the CD4+ T cell, since depletion of 
this subset prevented the rejection phenomenon. 
More recently (1997) Tarleton et al. repeated these experiments and obtained very different 
results. With lower parasite burdens the heart tissue was not rejected even after eight months. 
Using kinetoplastic DNA polymerase chain reactions (kDNA PCR) no T. cruzi forms were 
located in the tissue post transplantation. The authors maintained that the failure of the 
transplanted tissue to become parasitized demonstrates the efficacy of the immune response in 
controlling the spread of parasites to other sites of the body (Tarleton et al., 1997). This 
hypothesis supports previous observations of low levels of detectable circulating parasites in 
chronically infected hosts (Reviewed in Tarleton et al., 1997), as well as previous studies 
documenting the restriction of tissue parasites to the heart and skeletal muscle in C3H mice 
chronically infected with the SylvioX/10 clone of T. cruzi (Reviewed in Tarleton et al., 1997). 
When Tarleton and co-workers subjected the native hearts of chronically infected mice to kDNA 
PCR, they detected parasites in close association with inflammatory infiltrates. This finding 
provided evidence of an inflammatory process as the etiology for chronic Chagas' disease. This 
hypothesis is supported by a growing body of evidence connecting disease severity with the 
virulence of the infecting parasite strain, the persistence of parasites in the diseased tissues, and 
the efficacy of anti-parasite chemotherapy {Reviewed in Tarleton et al., 1997). In addition, Arif 
(1996) demonstrated that the lower numbers of circulating parasites observed in mice maintained 
at 36°C is correlated with lower levels of tissue parasitism, inflammation and tissue destruction. 
Immunity in T. cruzi infection 
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Infection with T. cruzi is accompanied by the down regulation of immune responses 
(Tarleton, 1991). The specific mechanisms that account for this suppression are not agreed 
upon, and likewise, neither is the significance of this phenomenon to the course of acute and 
chronic infection (Tarleton, 1991). It is believed that the immune system, although quite 
suppressed, is adequate to control the acute infection in most hosts (Tarleton, 1991). The onset 
of this immune response is correlated with the progression from the high parasitemias of the 
acute phase to virtually undetectable parasitemias in the chronic phase (Tarleton et al., 1996). 
There also exists strong evidence that the immunosuppressive response seen in chronic Chagas' 
disease is a contributing factor to disease development (Tarleton, 1991). 
IL-2 production has been shown to be severely depressed during the acute phase of T. cruzi 
infection (Harel-Bellan et al., 1983; Tarleton and Kuhn, 1984). The cellular and molecular 
mechanisms of this suppression are not yet clear (Tarleton, 1991). IL-2, known to play an 
important role as a T cell growth factor, has been shown to be influenced by CD8 + T cells in 
vitro and in vivo (Tarleton, 1991). Exogenous IL-2 administration can alter the immune 
responsiveness of lymphocytes from T. cruzi infected mice as well as the course of infection, but 
cannot completely overcome immunosuppression or result in a parasitological cure (Tarleton and 
Kuhn, 1984; Choromanski and Kuhn, 1985; 1987). 
T. cruzi infected mice have normal to elevated levels of IFN-y (Nabors and Tarleton, 1991). 
Serum levels are detectable until day 18-20 post infection at which time a significant drop is 
noted (Tarleton, 1991). This drop also corresponds to a decrease in IL-2 production (Tarleton, 
1991). IL-2 treatment of spleen cells from infected mice has been shown to increase IFN-y 
production, suggesting that IFN-y production is mediated by IL-2 (Tarleton, 1991). IFN-y has 
been shown to significantly decrease parasite load in vitro and in vivo (Reed et al., 1987; Wirth 
et al., 1985). However, the endogenous production seems to be insufficient to mediate resistance 
in vivo (Tarleton, 1991). Both IL-2 and IFN-y are secreted by the T helper subset TH1 
(Mosmann et al., 1986; Street and Mosmann, 1991). It has been suggested that there is either a 
selective suppression of TH1 cells for IL-2 production but not IFN-y production or that there is 
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complete suppression of TH1 cells and an alternative source of IFN-y such as varying T cell 
subsets or natural killer cells (Tarleton, 1991). These cell types have been reported to secrete 
IFN-y but only in in vivo antibody depletion studies. Nabors and Tarleton (1991) demonstrated 
that TH1 cells are the major producers of IFN-y in the spleens of T. cruzi infected mice, thus 
implicating a negligible role for other cell types. The TH2 cell subset, which secretes other 
cytokines such as IL-5, IL-6, and IL-10, is not necessarily suppressed nor markedly stimulated 
by T. cruzi infection (Tarleton, 1991). 
Because T. cruzi gains entrance into a wide variety of host cells, it was long thought to 
occupy a protective niche from immune destruction (Tarleton, 1990). While infected 
macrophages that have engulfed the organism are able to destroy it, the intracellular destruction 
of T. cruzi in other host cells such as smooth and cardiac muscles, neurons, and fibroblasts has 
not been widely reported (Tarleton, 1990). However, it has been shown that CD8+ cytotoxic T 
cells play a major role in the destruction of parasitized mammalian cells. The in vivo depletion 
of CD8 + T cells by anti-CD8 monoclonal antibody increased the susceptibility of both resistant 
and highly susceptible mouse strains to T. cruzi infection resulting in increased parasitemia and 
increased mortality (Tarleton, 1990; 1991). The crucial role that CD8 + T cells play in the 
immunity against T. cruzi was supported by another study that reported the failure of P2-
microglobulin-deficient mice which lack class I MHC molecules, to resist this parasitic infection 
(Tarleton, 1992). In addition, Ming (1994) and Guo (1994) demonstrated that the protective 
effect of elevated environmental temperature during experimental Chagas' disease is lost when 
mice are depleted o f C D 8 + T cells or CD4+T cells in vitro. Lytic antibodies may play a role in 
the lysis of extracellular trypomastigote forms, facilitate parasite uptake by phagocytic cells, and 
aid in antibody dependent cellular cytotoxicity (Reviewed in Tarleton, 1990). 
Therapeutic effects of fever and hyperthermia 
Rufus of Ephesus stated, "I think that you cannot find another drug which heats in a more 
penetrating manner than fever...and if there were a physician skillful enough to produce a fever, 
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it would be useless to seek any other remedy against disease" (Atkins, 1984). A fever or febrile 
response occurs in almost all infectious processes (Wan and Blackburn, 1992). Fever is defined 
as a physiological rise in core body temperature due to either an increase in the set point around 
which body temperature is normally centered, or a decrease in the thermal sensitivity of central 
heat sensitive neurons (Wan and Blackburn, 1992). A fever is characterized by a rise in core 
body temperature of approximately 2°C to 3°C above normal (Hansen, 1993). 
As early as the turn of the century, observations were being made concerning seasonal 
variations in the clinical manifestations of several infectious diseases including St. Louis 
encephalitis virus, rickettsial typhus, and diphtheria toxin in laboratory animals (Kolodny, 1939). 
Since the above mentioned diseases are caused by very different etiologic agents (a virus, a 
rickettsia, and a bacterium) it was hypothesized that these seasonal changes must be due to 
changes in the efficacy of the normal defense mechanisms of the hosts (Kolodny, 1939). 
The role that elevated temperature plays in overcoming pathogens has been widely 
recognized and studied. In 1927, Julius Wagner-Jauregg, an Austrian psychiatrist, was awarded 
the Nobel Prize in Physiology and Medicine for his work in developing a therapy for syphilis-
related paralysis that involved transfusing blood from patients infected with malaria to those 
suffering from syphilis in hopes that the high fever created by the malarial infection would 
reduce the syphilitic paralysis (Stine, 1992). 
Increases of temperature similar to a natural febrile response have been linked to decreased 
lesion scores, decreased fecal scores, and increased hematocrits in broiler chicks infected with 
Eimeria tenella (coccidiosis) (Anderson et al., 1976). Miyamoto et al. (1995) demonstrated that 
guinea pigs developed a graded fever response depending on the injected dose of Legionella 
pneumophila. Sublethal infections of L. pneumophila produced a lesser and more gradual febrile 
response that peaked at day three and returned to normal by day seven. The fever of lethally 
infected animals peaked at day one with a higher response and stayed high until day four. All 
guinea pigs given a lethal infection expired by day six. 
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Almost all bacteria that are pathogenic for humans are mesophilic (Mackowiak, 1981). Of 
these, many are very labile at temperatures > 41°C such as Streptococcus pneumonia and 
Niesseria gonorrhea (Mackowiak, 1981). Other bacteria such as Escherichia coli seem to be 
heat stable even at the upper limits of the febrile response (Mackowiak, 1981). For those species 
that are temperature sensitive, the effect seems to be directly upon the bacteria. At increased 
temperatures, decreased growth rates, synchronized cell division, changes in morphologies, 
decreased motility, and damage to cell walls leave the bacteria very vulnerable to damage 
(Mackowiak, 1981). Many instances of improved clinical outcome have been documented in 
association with an elevated body temperature of 40°C (Mackowiak, 1981). For example, 
elevated body temperature is restrictive to the growth of Haemophilis influenzae in the cerebral 
spinal fluid of rabbits (O'Reilly and Zac, 1992). An increased survival is also noted in rabbits 
when a fever is mounted to Pasteurella multocida infection (Kluger and Vaughn, 1978). 
Retrospective studies on meningetic patients showed that mortality is significantly lower in 
patients with fever than in patients without fever or with hypothermia (O'Reilly and Zac, 1992). 
Elevated body temperature also has been correlated with improved outcome in spontaneous 
bacterial peritonitis (Weinstein et al., 1978), gonorrhea, and neurosyphilis (Rodbard, 1981). 
Whole body hyperthermia (WBH) has been shown to have intrinsic cytoreductive potential 
and to lead to dramatic but short term remission in a number of malignancies (Robins et al., 
1989). This phenomenon may be partially accounted for by the extreme heat sensitivity of cells 
actively undergoing mitosis. The aggregation of globular proteins in the spindle apparatus or the 
disaggregation of spindles renders the cells unable to complete the mitotic division (Overgaard, 
1977). WBH also has been used as an adjunct to radiation and chemotherapy (Robins et al., 
1989). Analysis from several experiments performed by Robins and co-workers suggests that 
WBH may impart myeloprotection at this critical time of white blood cell nidar. These 
investigators showed that there were increases in the G-colony stimulating factors IL-lb and IL-
6, both of which are cytokines that may play a role in stimulating myeloid, erythroid, and 
megakaryocyte progenitor cells, and thus may increase platelet, red blood cell, and white blood 
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cell counts in patients. Recently, hyperthermia has been used in the multi-model treatment for 
HIV and is hypothesized to decrease the number of mutant HIV strains arising early in the 
disease process (Owens and Gasper, 1995). Hyperthermia also has shown unexpected success in 
the treatment of Kaposi's sarcoma (Steinhart et al., 1996; Logan and Alonso, 1991; Alonso et al., 
1992). 
Although the positive effects of an elevated temperature on various disease states have been 
well established, no one has been able to explain the mechanism(s) that accounts for this 
phenomenon. It seems that in every experiment a different mediator is implicated. The reason 
for the disparity is most likely due to fever being a multifactorial process. 
T cells have been shown to be a major player in the enhanced immune response seen in 
febrile conditions. The increased immunity involves T cell proliferation (Gern et al., 1991), T 
cell dependent humoral responses, T cell secretion of interleukin-2, and T cell-mediated 
macrophage activation (Jampel et al., 1983). 
An elevated in vitro temperature of 40°C has been shown to have profound effects upon 
murine macrophage function including increases in cytotoxic activity, phagocytosis, Fc receptor 
expression, spreading, and oxidative burst (Van Bruggen et al., 1991). Elevated temperatures 
also have been shown to amplify the induction of nitric oxide (NO) synthesis (Bernard et al., 
1994). NO's appear to provide a protective mechanism against intracellular parasitism in rodents 
(Green etal., 1991). 
Another factor that may contribute to the protection observed in an elevated temperature 
response is heat shock proteins (HSPs). HSPs are produced by cells in response to certain 
stresses (Dimock et al., 1992). They play a very important role in the ability of cells to 
withstand high temperatures (Welch, 1992), exposure to the cytotoxic effects of tumor necrosis 
factor alpha and beta (Jaattela et al., 1989) and IL-1 (Margulis et al., 1991), oxidative injury 
(Healy et al., 1992), and to the lethal effects of bacterial endotoxins (Ryan et al., 1992; Hotchkiss 
et al., 1993). Heat shock proteins on the parasite can serve as targets of the immune response and 
parasitic HSPs may be among the most immunogenic of all parasitic antigens (Hedstrom et al., 
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1988; Newport et al., 1988; Engman et al., 1990; Young, 1990). Since HSPs exist on all cells 
and a high degree of 
sequence homology exists between host HSP and T. cruzi HSP, these have been implicated as a 
potential mechanism in auto-immune pathology (Newport et al., 1988; Mattei et al., 1989; 
Young, 1990). However, Engman et al. (1990) have down-played this theory by demonstrating 
that antibodies to parasite HSP 70, the major target of antibodies in infected persons, were highly 
specific for parasite HSP and did not cross react with the homologous human HSP. 
The effects of elevated environmental temperature on American trypanosomiasis 
Due to the fact that T. cruzi is prevalent in tropical climates and commonly demonstrates a 
chronic intermittent pathogenicity in vertebrates, investigators began to question if the 
supranormal ambient temperature somehow contributed to the host's ability to survive acute 
infection and curtail the course of disease. In 1939, Kolodny showed that mice infected with a 
lethal dose of T. cruzi from October until May developed very high parasitemias within 20 days 
and had a near 100% mortality rate. In contrast, mice infected in July or August developed 
lower parasitemias and exhibited approximately 80% survival. In 1940, Kolodny took this work 
further and set up an experiment that kept infected mice at three different environmental 
temperatures; (1) room temperature, (2) 40°F-45°F (designated "cold stress"), and (3) 90°F-95°F 
(designated "heat stress"). The cold stress group maintained a rectal temperature of less than 1°F 
below normal rectal temperature and yet developed parasitemias several times more intense than 
any other group. All mice in the cold stress group died. There was a 100% survival rate in the 
other two groups with infected mice in the heat stress group displaying much lower parasitemias. 
Interestingly, Kolodny noted that the elevated temperature group had an increase in rectal 
temperature of 2°F to 3°F. Kolodny concluded that this 2°F to 3°F elevation in body 
temperature slightly increased the resistance of the mice to T. cruzi. This resistance was 
manifested by lower parasitemia levels and increased survival. However, a less than 1°F lower 
body temperature led to a much more intense infection with much higher parasitemia levels and 
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fatality. In 1965, Trejos et al. observed that when mice were placed at 18°C vs. 37°C very 
specific temperature to parasitemia level ratios were evident. If given a non-lethal infection with 
T. cruzi, the mice at 18°C developed much higher parasitemias than those at 37°C. If the mice 
originally held at 18°C were then transferred to a 37°C environment, parasitemia levels dropped 
dramatically after four days. When the reverse experiment was performed and the mice 
originally at 37°C were moved to an 18°C environment, rapid increases in parasitemia levels 
were seen. If lethal infections of T. cruzi were given, all mice in the 18°C group died while only 
50% of the mice died in the 37°C group. The authors went a step further and tried to determine 
if death of mice was due to myocardial effects of the parasite. Histological sections revealed 
numerous parasites within the myocardium with subsequent severe myocarditis in all mice in the 
18°C group, while there was no evidence of pathology in mice in the 37°C group. 
In 1966, a scientist by the name of Marinkelle was completing a five year study of Chagas' 
disease in Columbia. At this time he had estimated that approximately two million Colombians 
harbored T. cruzi, a large number of whom were apparently healthy carriers. He began to ponder 
the significance of this "healthy" carrier state in relation to the warm tropical climate. In 1968, 
he and Rodriguez published a paper addressing the influence of environmental temperature on 
the pathogenicity of T. cruzi. Their work supported the results of previous studies demonstrating 
that there was an inverse correlation between temperature and intensity of disease. Marinkelle 
and Rodriguez demonstrated greater than 90% survival in mice held at 36°C up to 180 days post 
infection in contrast to 100% mortality in mice held at 25°C by day 15 post infection. The 
authors hypothesized that this protection was mediated by some natural immune phenomenon 
and that the relative increase in the ambient temperature in many areas where Chagas' disease is 
endemic may result in the rapid activation of this response thus protecting many individuals 
infected with T. cruzi. 
After nearly three decades of research, it was well documented that maintenance of animals at 
elevated temperature resulted in lower parasitemias and decreased mortality during infection 
with T. cruzi. Such results brought about the obvious question: is the response seen in elevated 
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temperature due to an effect on the parasite's ability to cause disease or to the immune system's 
ability to combat disease? 
Elevated temperature effects on the parasite 
Although most research has indicated an immune enhancement due to elevated temperature, 
there are several works that describe a direct temperature effect on the parasite itself. The two to 
three degree elevation in core body temperature produced by an ambient temperature of 36°C is 
not directly lethal to parasites (Otieno, 1973). As stated previously, parasites are very capable of 
infecting immunocomprimised hosts maintained at 36°C (Otieno, 1973). However, the increased 
temperatures have been shown to result in some physiological changes. In vitro studies have 
shown that some strains of T. cruzi are unable to differentiate from the amastigote to the 
trypomastigote form at 37°C to 38°C (Bertelli et al., 1977; Neva et al., 1961). In other studies 
this result has been contradicted, and an increase in the penetration of cells by trypomastigotes 
has been seen at these temperatures (Dvorak and Poore, 1974). The major consequences of a 
higher temperature were noted in changes in the time required by the parasite to transverse the 
lag period and reproductive phase (Dvorak and Poore, 1974). An increase in environmental 
temperature from 29°C to 35°C caused the lag period, i.e., the time interval between the 
penetration of the host cell by a trypomastigote and the onset of reproduction by an amastigote, 
to decrease linearly (Dvorak and Poore, 1974). This lag period changed from 39.8 hours at 32°C 
to 18.4 hours at 38°C (Dvorak and Poore, 1974). Thus it would seem that an elevated 
temperature environment actually benefited T. cruzi by enhancing penetration and decreasing the 
lag time. However, the doubling time (the time required for reproduction) increased from 12 
hours at 32°C to 15.7 hours at 38°C (Dvorak and Poore, 1974). Despite the altered times of 
events seen with varying temperatures between 29°C and 36°C, the course of the intracellular 
cycle was essentially the same. 
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In 1972, Otieno reported that the pathogenicity of various strains of T. cruzi at room 
temperature versus elevated temperature was strain specific. In 1973, Otieno also reported that 
T. brucei or T. cruzi transformed from a predominately monomorphic long form to a 
pleomorphic mixture of long and stumpy forms when mice were maintained at 36°C. 
Elevated temperature effects on the host immune response to T. cruzi 
In 1967, Amrein demonstrated that the immunosuppressive corticotropic hormone, Decadron, 
could reverse the beneficial effects of elevated environmental temperature. Infected mice 
maintained at elevated temperature but treated with Decadron showed a 60% mortality rate with 
numerous trypanosomes present in the peripheral blood and heart tissue. This result provided 
evidence that the temperature effects were an immunological phenomenon rather than due to 
direct effects of temperature on the parasite. In these studies, the parasite was very capable of 
inducing pathogenesis and mortality and the only change had been in the drug lowering the 
immune status of the mice. Following Amrein's studies, several different experiments were 
performed using immunosuppressive agents such as cyclophosphamide (Otieno, 1973; Dimock 
et al., 1992) and whole body irradiation (Otieno, 1973). The results again showed that 
immunosuppressive treatment prior to inoculation with a lethal dose of T. brucei or T. cruzi 
reversed the positive effects otherwise noted in an elevated temperature environment. Serologic 
analysis of the irradiated mice in Otieno's study failed to demonstrate agglutinating or 
precipitating antibodies on the ninth and twelfth day post infection, days in which nonirradiated 
mice developed strong responses of this type. This result indicates that the humoral response of 
mice was impaired by irradiation. 
In 1989, Anderson and Kuhn turned their investigations toward determining the aspects of the 
immune response which were important for the development of resistance to T. cruzi at elevated 
environmental temperatures. They looked at a broader scope of the elevated temperature effects 
to include not only parasitema levels and longevity but also antibody responses and T. cruzi-
specific helper cell responses to heterologous antigens. To determine exactly how ambient 
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temperature influences body temperature, rectal probes were used to monitor temperature 
fluctuations of mice held at room temperature versus 36°C throughout the day. All mice 
exhibited similar circadian rhythms with the peak temperatures occurring at approximately 3 
A.M. and the low body temperatures occurring in the early afternoon as would be typical for 
nocturnal animals. Temperature ranges for mice held at 25°C ranged from 33.7°C to 35.7°C. 
Temperatures for those maintained in the 36°C environment ranged from 37.4°C to 38.8°C. This 
increase is very similar to that seen in a natural febrile response. The effect of increased 
environmental temperature on antibody production to sheep red blood cells (srbc) was measured 
on day 25 and 35 of infection and compared with the responses of age matched noninfected 
controls (Anderson and Kuhn, 1989). Day 25 was chosen because it is at this time the acute 
phase of infection is rapidly progressing when mice are maintained at room temperature. Day 35 
represents the time of highest parasitemia just prior to death (Anderson and Kuhn, 1989). Mice 
maintained at 36°C showed a significantly greater anti-srbc direct plaque forming cell (DPFC) 
response than mice kept at room temperature. The noninfected control mice in both groups 
demonstrated a slightly greater response than either of the infected groups, thereby indicating 
some degree of suppression of parasite-induced antibody formation. On day 25, the 36° C mice 
showed a significantly greater DPFC response than infected mice at room temperature. "On day 
35 of infection the DPFC response to srbc from mice held at 36°C was much higher than that of 
infected mice held at room temperature and was in fact slightly higher than the DPFC response 
of age-matched noninfected controls" (Anderson and Kuhn, 1989). Suppression of parasite 
specific T cell responses was measured using T. cruzi conjugated to the hapten trinitrophenyl 
(TNP-JC). The DPFC response to TNP-TC from infected mice kept at 36°C was slightly higher 
than for those mice kept at room temperature indicating that maintaining mice at an elevated 
temperature may abrogate parasite specific suppression of T helper cell responses (Anderson 
and Kuhn, 1989). 
In 1991, Dimock et al. investigated the production of parasite specific antibodies in protected 
mice. Previous studies had indicated an enhanced ability of B cells to produce antibody at 
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elevated temperatures both in vitro (Reviewed in Dimock et al., 1991) and in vivo in T. cruzi-
infected mice (Anderson and Kuhn, 1989). The results of the study performed by Dimock and 
co-workers showed that mice held at room temperature developed very high parasitemias, high 
levels of antibodies, and had a 100% mortality rate. In contrast, mice held at 36°C displayed low 
parasitemia levels, low detectable antibody levels, and had a 100% survival rate. The latter 
group did not show a peak in parasitemia until much later than day 35, which is the day of peak 
parasitemia in mice held at room temperature. Dimock et al. suggested that antibodies could 
play a protective role later in infection at elevated temperature, but this effect was not measured 
in their study. The authors also proposed that in the early course of infection, low levels of 
antigenic stimulation may inhibit antibody formation and, therefore, some other aspect of the 
immune response must be responsible for the observed protection. It was suggested that cell-
mediated factors such as T helper cell responses which have been shown to be enhanced at the 
time of acute infection (Anderson and Kuhn, 1989) and interleukin (IL) activity including IL-1 
(Duff and Durum, 1983) or IL-2 (Choromanski and Kuhn, 1985) may be playing a role early in 
infection. Dimock and co-workers clearly indicated little role for parasite-specific antibodies in 
the resolution of acute infection with T. cruzi. The level of antibody produced did not 
correspond with survival but rather showed a linear relationship that correlated with parasite 
number. If noninfective culture forms of T. cruzi were injected into mice maintained at 36°C 
during the acute phase, heightened antibody production was observed. This result implied that 
low antibody levels were due to low parasite number and not vice versa. 
In 1992, Dimock et al. performed an experiment designed to measure antibody production in 
mice held at elevated temperature throughout the course of infection. A parasite-specific ELISA 
was used to measure levels of anti-T. cruzi IgG in the sera of infected mice. In mice maintained 
at 36°C, a progressive increase was noted throughout the course of infection. Immunoblot 
assays indicated that the reactivity of parasite-specific antibodies increased to a peak at day 91 
post infection. Interestingly, parasite levels were almost completely undetectable at this time. 
The authors also investigated the nature of surface antigens produced by blood-form 
20 
trypomastigotes (BFTs) held at 36°C versus room temperature. At day 25, BFTs from mice 
maintained at 36°C produced a 61 kDa antigen that reacted strongly with sera from mice kept at 
this temperature. This response remained strong throughout infection. This same antigen 
reacted only weakly with sera taken from mice kept at room temperature and was not recognized 
prior to day 25. An antigen of similar molecular weight was produced by BFTs of mice held at 
room temperature, but in a much more limited quantity. Mice at both temperatures produced a 
19 kDa parasite antigen, however, a more intense reaction was seen with sera from the 36°C 
mice. These results suggested either variable antigenic presentation or various immunogenic 
properties of antigens at the two temperatures. The results also provided evidence for a strong 
antibody response in mice held at 36°C. This response showed a delayed onset and did not 
correlate with parasitemia levels. 
Passive transfer of immunity 
Passive transfer of immunity refers to the injection of preformed antibodies or immune sera 
into a naive host. The protection offered by the humoral branch of the immune system is largely 
only effective against pathogens free in the serum and not against intracellular entities. 
Antibodies play several important roles in pathogen destruction including neutralization, 
immobilization, or agglutination (Janeway and Travers, 1996). Thus antibody participates in 
direct pathogen inactivation. Antibodies can also perform different rolls such as opsinizing 
antigens to facilitate destruction by macrophages or antibody-dependent cell-mediated 
cytotoxocity (ADCC) via natural killer cells or other cells which bear Fc receptors for 
immunoglobulin (Janeway and Travers, 1996). Antibody can also bind to solubilized antigen, 
which is protected from other immune components, and form a complex that readily precipitates 
(Janeway and Travers, 1996). Once it is in this state, macrophages or the complement cascade 
can destroy it (Janeway and Travers, 1996). In fact, an antigen/antibody complex is required for 
the activation of the classical complement cascade (Janeway and Travers, 1996). In addition, B 
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cells can act as antigen presenting cells to T cells in much the same way as macrophages, except 
they are uniquely adapted to the uptake of soluble antigens (Janeway and Travers, 1996). 
Adoptive transfer of immunity 
Adoptive transfer refers to transfer of the capacity to make an immune response by the 
transplantation of immunocompetent cells (Benjamini and Leskowitz, 1988). The source of 
adoptive transfer is commonly attributed to T cell function, and thus is also termed cellular 
immunity. However, cellular immunity is multifactorial, and although T cells are the major 
players, many other cellular elements may also be involved. 
T cells are produced in the bone marrow and mature in the thymus. Once mature, they 
circulate in the peripheral lymphoid organs. Naive T cells must be activated by the presentation 
of specific antigens on the surface of specialized antigen presenting cells i.e., alveolar, splenic, 
and peritoneal macrophages; dendritic cells located in the spleen, lymph node, and skin; Kupffer 
cells in the liver; or microglial cells in the CNS (Janeway and Travers, 1996). Antigen 
presenting cells which are located along capillary beds make first contact with a nonspecific 
invading antigen (Janeway and Travers, 1996). They engulf it, denature the antigen, and place 
peptide fragments of the antigen onto surface proteins known as major histocompatability 
complex (MHC) proteins (Janeway and Travers, 1996). In this way, an antigen is presented to a 
T cell (Janeway and Travers, 1996). The cells possess two different types of cluster of 
differentiation molecules, which are surface glycoproteins, termed CD4 and CD8. If a 
presenting cell uses a MHC class I molecule to present an antigen it will be recognized by T cells 
bearing the CD8 on it's surface (Janeway and Travers, 1996). These are commonly called 
cytotoxic T cells and are involved in the direct killing of the target cell (Janeway and Travers, 
1996). If the presenting cell uses a MHC class II molecule to present the antigen, it will be 
recognized by T cells that have a CD4 glycoprotein (Janeway and Travers, 1996). CD4 bearing 
T cells are divided into two groups, TH1 and TH2 cells (Janeway and Travers, 1996). The 
activation of either TH1 or TH2 cells is a profound decision and appears to be mediated, at least 
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in part, by the cytokines IL-4 and IL-12 (Janeway and Travers, 1996). If TH1 cells are activated 
they function to activate infected macrophages to destroy intracellular pathogens (Janeway and 
Travers, 1996). This process amplifies cell-mediated immunity (Janeway and Travers, 1996). If 
TH2 cells are activated they in turn activate B cells to produce more antibody, and thus amplify 
the humoral response (Janeway and Travers, 1996). Helper T cells secrete an array of B cell 
activating cytokines (IL-4, IL-5, IL-6, and IL-10) (Janeway and Travers, 1996). Inflammatory T 
cells secrete cytokines that activate macrophages such as IL-2, I FN-v, and TNF-/J (Janeway and 
Travers, 1996). Cytotoxic T cells also release IFN-j which activates natural killer cells 
(Janeway and Travers, 1996). 
Previous studies on the transfer of immunity to T. cruzi 
In 1979, Guhl and co-workers performed experiments designed to determine if the immunity 
acquired at elevated environmental temperature could be transferred to naive recipients. Three 
groups of mice were given an inoculant of a lethal dose of the Tulaheun strain of T. cruzi. Group 
A mice were maintained at 36°C and served as serum donors for group C. Group B mice were 
maintained at 25°C, and mice in Group C were maintained at 25°C plus were given daily 
injections of 0.2 ml of serum from Group A. The mean survival in each group was as follows: 
Group A-230 days, Group B <13 days, and Group C >350 days. Since the antibodies produced 
by the heat-stressed mice were apparently able to passively impart protection, it was concluded 
by the authors that the protection was due to increased stimulation of the immune system and not 
due to the direct effect of high temperature on the parasite. This conclusion was further 
supported by the fact that the parasites that infected Group C had never been exposed to the 
increased ambient temperature. 
In 1975, Kuhn and Durum tried to determine the kinetics of the immune response against T. 
cruzi by injecting recipient mice with spleen cells from donor mice at varying days post 
infection. They found no increase in survival until nine days post-infection. From this point the 
longevity of recipient mice increased in proportion to the duration of infection of the donor mice. 
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Thus, the onset of immune protection in acute experimental Chagas' disease seems to occur 
between six and nine days post-infection. This time span corresponds with the first intracellular 
cycle as described by Dvorak and Hyde in 1973. They observed that intracellular proliferation 
and subsequent escape of trypomastigotes takes six and one-half days and results in 
approximately 512 parasites per invaded host cell. " If the sum of these observations can be 
applied to the event leading to the development of immunity in vivo, then one might assume that 
the first extensive interaction of the host's immune system with the parasite and its elaborate 
products, if any, would not occur at the time of infection, but rather at the time of the release of 
parasites following the first intracellular cycle" (Kuhn and Durum, 1975). 
The humoral branch of the immune response has been shown to be enhanced in mice 
maintained at 36°C as indicated by increased levels of anti T. cruzi antibodies late in infection 
(Dimock et al., 1991; Dimock et al., 1992). Other research that supports increased antibody 
production at elevated environmental temperatures has been reported by Culbertson and 
Kolodny, 1938; Kolodny, 1940; Robertson et al., 1973. The positive effects of antibody coupled 
with complement was reported by Budzko et al., 1975. 
The positive effects of T cell-mediated processes on immunity against T. cruzi also have been 
reported. Ming, 1994 and Guo, 1994 demonstrated that the depletion of CD8 or CD4 T cells in 
vivo by the use of monoclonal antibodies resulted in an abrogation of the protective effects of 
elevated temperature during acute Chagas' disease. Trischmann and Bloom (1980) reported that 
when whole spleen cells from mice previously immunized against T. cruzi, with noninfective 
epimastigote forms, were injected into an infected recipient group all mice given spleen cells 
prior to eight days post-infection died and all mice receiving spleen cells past eight days post 
infection survived. 
Nogueira et al. (1981) were able to reproduce these results by injecting naive recipients with 
whole spleen cells from mice that had been given a sublethal infection of T. cruzi. The whole 
spleen cells also were tested in vitro for the presence of macrophage activating factors. Such 
factors were successfully isolated from whole spleen cells. B cell depleted spleen cell 
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populations were found to be as effective as whole spleen cells in both the ability to confer in 
vivo protection in passive transfer experiments and to generate in vitro macrophage activating 
factor(s). This phase of the experiment was based upon earlier studies demonstrating that 
macrophages became trypanocidal during the course of an infection with T. cruzi or by exposure 
to factor(s) derived from antigen or mitogen stimulated lymphocytes (Reviewed in Nogueira et 
al., 1981). 
A very important background study for the experiment presented in this thesis was performed 
by Rowland and Ritter in 1984. In this work, they immunized mice with a less virulent strain of 
T. cruzi two weeks prior to challenging the mice with a lethal dose of a virulent strain of T. cruzi. 
All mice survived the otherwise lethal infection. When the immune system was experimentally 
separated into adoptive and passive components the results were very similar to the results 
obtained in the present study. While whole spleen cells from the immunized mice that had 
survived challenge with the lethal forms of T. cruzi were found to be able to adoptively transfer 
immune protection to naive recipients, no protection was imparted by either spleen cells from the 
control mice or spleen cells from mice that had only received the vaccine but had not survived a 
lethal challenge. Passive transfer conferred a short term protection that was evident at day 21 
post infection by lower parasitemias than the controls. However, by day 28 the status of 
recipient mice was no different than for the controls. 
Murine model 
The murine model has become the standard for studying experimental Chagas' disease. It is 
important to remember when looking at various works ,with varying results, that inbred strains 
of mice have been found to differ greatly in their natural resistance to T. cruzi (Reviewed in 
Nogueira et al., 1981). The C3HeB/FeJ mice used in the present study have been accepted as the 
strain best exemplifying susceptibility to T. cruzi (Rowland and Ritter, 1984). The age 
(Culbertson and Kessler, 1942) and sex (Hauschka, 1947) of mice also influences the course of 
T. cruzi infection (Trischmann et al., 1978). When C3HeB/FeJ mice are infected with T cruzi, 
25 
they develop a significant immunosuppression that involves both nonspecific (humoral and cell-
mediated) and parasite-specific responses (Cunningham and Kuhn, 1980; Kuhn, 1981; Tarleton 
and Kuhn, 1985). 
Goals of the present study 
The goals of the present study were 1) to confirm that maintenance of lethally infected 
C3HeB/FeJ mice at an elevated environmental temperature of 36°C significantly lessens the 
course of infection with T. cruzi, 2) to determine if this increased resistance could be transferred 
to naive recipient mice held at 21°C, and 3) to determine if the immune system enhancement by 
an ambient temperature of 36°C could be attributed to the components of humoral immunity by 
the transfer of sera or to the components of cellular immunity via transfer of whole spleen cells. 
Chapter 2 
Materials and Methods 
Mice 
In Phase 1 of the study - 24 female C3HeB/FeJ mice obtained from the Jackson Laboratory 
(Bar Harbor, Maine) were utilized. All mice were acclimated at room temperature (21°C) for 
three weeks prior to use. They were eight weeks old at the time of intraperitoneal (i.p.) injection 
with 1000 blood-form trypomastigotes (BFTs). 
In Phase 2 of the study - 20 C3HeB/FeJ mice (17 female and 3 male) were used from a pre-
existing breeding colony maintained in the Department of Biology of Western Kentucky 
University. These mice required no acclimation time and were infected i.p. with 1000 BFTs at 
eight weeks of age. 
Twenty female C3HeB/FeJ mice obtained from the Jackson Laboratory were utilized in Phase 
3 of the study. All mice were acclimated at room temperature (21°C) for greater than three 
weeks prior to use. They were eleven weeks old at the time of i.p. infection with 1000 BFTs. 
Parasites 
Mice were infected with the Brazil strain of T. cruzi which is maintained in this laboratory as 
a stock infection in C3HeB/FeJ mice. Parasites were harvested via a cardiac puncture performed 
immediately post cervical dislocation of a donor mouse. One ml of blood was recovered and 
placed in ten mis of sterile Dulbecco's phosphate buffered saline (DPBS; Gibco Laboratories, 
Grand Island, New York). The suspension was centrifuged at 1800g for 15 minutes in order to 
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wash the parasites free of any donor antibodies and other serum components. The supernatant 
was decanted and discarded. Then, 15 ml of fresh sterile DPBS was added and gentle vortexing 
was applied in order to resuspend the solution. The BFTs were counted using a hemacytometer 
and the parasite suspension was diluted in sterile DPBS to a final concentration of 5 x 103 
parasites/ml of blood. 
Following infection, mice were either maintained in the animal facility in the Department of 
Biology at Western Kentucky University at room temperature (21°C) or were placed in an 
environmental chamber which was held at a temperature of 36°C. Both conditions were kept 
under a 12 hour light/12 hour dark photoperiodic cycle. Food and water were provided ad 
libitum. All mice were maintained and used in accordance with local IACUC guidelines. 
Experimental design 
Phase 1- The mice in this phase were used as donors for the passive and adoptive transfer 
experiments. Six mice were infected and immediately placed in the room temperature 
environment (RTI). Six mice were infected and immediately placed in the elevated temperature 
environment (ETI). There also were accompanying noninfected control groups (RTNI and 
ETNI) at each temperature. Both room temperature groups were euthanised at day 35 post 
infection. Day 35 was chosen because C3HeB/FeJ mice have been shown to succumb to a lethal 
infection of T. cruzi between day 35 and 45. One mouse died prior to this date and the others 
were showing obvious signs of deterioration and oncoming expiration at this time. Mice 
maintained at elevated temperature were euthanised on day 98 of infection, after parasitemia 
levels had dropped to zero. 
Phase 2- The mice in this phase were naive recipients of either whole spleen cells or sera 
from the room temperature infected and noninfected groups of Phase 1. Four groups of five 
mice each received the following treatments: 
Group 1 = room temperature infected whole spleen cells (RTI spleen). 
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Group 2 = room temperature infected sera (RTI sera) 
Group 3 = room temperature noninfected whole spleen cells (RTNI spleen) 
Group 4 = room temperature noninfected sera (RTNI sera) 
All recipient mice were maintained continuously at room temperature. 
Phase 3 - The mice in this phase were naive recipients of either whole spleen cells or sera 
from the elevated temperature infected and noninfected groups of Phase 1. Four groups of five 
mice each received the following treatments: 
Group 5 = elevated temperature infected whole spleen cells (ETI spleen). 
Group 6 = elevated temperature infected sera (ETI sera) 
Group 7 = elevated temperature noninfected whole spleen cells (ETNI spleen) 
Group 8 = elevated temperature noninfected sera (ETNI sera) 
All recipient mice were maintained continuously at room temperature. 
Serum preparation 
Serum was chosen for passive transfer experiments because it contains the highest 
concentration of immunoglobulin. Donor blood was harvested by cardiac puncture and allowed 
to clot. It was then centrifuged at approximately 1500 rpm for 10 minutes. Sera were removed 
and divided into 0.6 ml aliquots which were placed into microcentrifuge tubes and stored at -70° 
C until use. All sera used in this experiment had only been subjected to one freeze-thaw cycle. 
Each mouse receiving sera was given an i.p. injection of 0.1 ml 24 hours prior to infection and 
every subsequent week for a total of four weeks. Weekly injections were given due to the fact 
that the shortest half life of any IgG subset is seven days (Benjamini and Leskowitz, 1989). 
Source of cellular components 
Spleen cells were chosen for adoptive transfer experiments due to the fact that the splenic 
white pulp is rich in both T and B cells and the splenic red pulp is rich in macrophages. 
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Spleens were aseptically removed immediately post mortem of the donor mice and placed into 
serum-free RPMI-1640 medium. Large forceps were used to gently disrupt the splenic capsule. 
The freed spleen cells, floating free in the media, were drawn into a 10 ml syringe through a 22 
gauge needle and expelled slowly through a 26 gauge needle into a sterile tube. This step 
released the spleen cells from the splenic matrix. The cell suspension was centrifuged at 1500 
rpm for 10 minutes. The supernatant was decanted and the cells were resuspended in 0.5 ml lx 
DPBS. The red blood cells were lysed via hypotonic shock by adding 4.5 ml of distilled water 
and then in less than ten seconds adding 0.5 ml of lOx DPBS to restore tonicity. The suspension 
was centrifuged again at 1500 rpm for 10 minutes. After this procedure, RBC "ghosts" were 
mechanically removed. Spleen cells were resuspended in 5 ml of serum-free RPMI-1640 media. 
The cells were then quantified using a hemacytometer. Each mouse was injected i.p. with 1 x 
10^ whole spleen cells 24 hours prior to infection. This treatment was administered only once. 
Parasitemias 
Parasitemia levels were monitored in all infected mice beginning at day 13 post infection and 
continuing every 3 to 4 days throughout the course of infection. A 4 | x l sample of blood was 
taken from the tail and diluted in 96 of lx DPBS. Parasitemias were counted using a 
hemacytometer and an Olympus microscope. Mice were closely monitored for morbidity and 
mortality. 
Statistical analysis 
All statistical analyses were done using Systat (Wilkinson, 1992). For each treatment group, 
peak parasitemia (highest parasitemia reached by any mouse in a given treatment group) and the 
day on which the peak occurred were determined. These values were log transformed to 
equalize variances among treatment groups prior to analysis of variance. Treatment groups were 
tested for significant differences in the day post infection that peak parasitemia was observed per 
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group, the peak number of parasites/ml of blood reached by each group, and their interaction 
using MANOVA. 
Probabilities for individual treatment groups were calculated using a Tukey's HSD multiple 
pairwise comparison procedure. This test was employed to assess significance of comparisons 
involving the ETI spleen group. Because it corrects for the large number of simultaneous tests 
performed, the HSD test biases the comparisons against finding any significant difference 
between ETI spleen group and the other seven treatment groups. Differences were considered 
significant at the P < 0.05. 
Chapter 3 
Results 
Effect of elevated temperature on parasitemia 
Mice infected with a lethal injection of T. cruzi were placed at either 21°C or 36°C in order to 
determine the effects of environmental temperature on parasitemia and course of disease. The 21 
°C group demonstrated an average onset of parasitemia beginning at day 14.6 post infection (see 
Table 1). BFTs showed a rapid and steady increase in number in this group until time of 
euthanasia (day 35) when parasite levels were at their highest with a mean peak of >700 x 10^ 
parasites/ml of blood (see Fig. 1). The mice maintained at room temperature were clinically 
emaciated in the latter days of infection and one succumbed prior to day 35 post infection. Mice 
in the 36°C group displayed a delayed onset of parasitemia beginning at day 20 and a much 
slower progression of parasitemia beginning at approximately day 35 and peaking on day 74 at 
272 x 10^/ml of blood, less than half the number of parasites observed in the 21°C group (see 
Fig. 1). This group began a decline in parasite numbers beginning at day 80 and progressing to 
essentially undetectable levels by day 90 post infection. Clinically, five of these mice appeared 
healthy throughout infection. However, one mouse within this group showed a spike in 
parasitemia of 1400 x 10^ on day 74 and died on day 75 post infection. No survival results are 
reported on either of these groups of mice because they were not allowed a natural course of 
infection, but instead were euthanised to accommodate the design of this study. Given that 80% 
of the mice held at 36°C were able to exhibit lower parasite numbers and resolve parasitemia, it 
was of interest to determine if the protection imparted by elevated environmental temperature 
could be adoptively or passively transferred to naive infected mice maintained at 21°C. 
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Effect of passive transfer of sera on parasitemia and survival 
To evaluate the contribution of antibodies and other serum components to the altered course 
of infection including lower parasitemias, increased longevity, and eventual clearing of BFTs 
noted in infected mice held at 36°C, pooled sera from infected and noninfected mice maintained 
at 36°C, as well as, from infected and noninfected mice maintained at 21°C were transferred to 
four sets of naive mice. Recipient mice were given a lethal dose of T. cruzi and held at 21°C for 
the duration of the experiment. Transfer of sera from infected mice held at both temperatures 
resulted in an average onset of parasitemia of 14.2 days (see Table 1). In all cases the 
parasitemia levels began to increase at approximately day 20 post infection, and continued to 
rise, reaching levels exceeding those of the respective controls and those seen with the 21°C 
donor mice (see Table 1). All mice receiving sera died on days 35-59 post infection (see Fig. 3). 
Effect of adoptive transfer of spleen cells on parasitemia and survival 
Administration of whole spleen cells was utilized to determine if the enhanced immune 
responsiveness seen at elevated temperatures, including lower parasitemia and increased 
survival, could be adoptively transferred to infected mice held at 21°C. The groups receiving 
spleen cells from both the 21°C and 36°C donor mice had an average onset in parasitemia of day 
15.8 and the lowest peak parasitemia levels of all treatment groups (415 X 10^ and 14 X 10^ 
resp.). However, only the group receiving whole spleen cells from infected mice maintained at 
elevated temperature showed significant difference in peak parasitemia levels. The mice 
receiving spleen cells from the 21°C group and the noninfected controls displayed a general 
trend resembling that seen for the 21°C group with rapid increases in parasitemia levels 
beginning at approximately day 20 post infection and continuing to increase to similar peak 
levels (see Table 1). The groups receiving noninfected whole spleen cells (ETNI whole spleen) 
as well as whole spleen cells from the 21°C infected mice (RTI whole spleen) and the 21°C 
noninfected mice (RTNI whole spleen) had a 100% mortality rate on day 36-55 post infection 
(Fig. 2). However, those mice receiving the whole spleen cells from the mice originally 
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maintained at 36°C demonstrated a very significant difference in pattern of infection. The mice 
in this group displayed very low parasitemias with a mean peak of 14 x lO^/ml of blood and 
rapidly cleared the BFTs by approximately day 40 of infection. These parasite levels were 
considerably lower than seen in the original mice that survived infection at 36°C and served as 
donors for this group. 
Results of statistical analysis 
Although peak day, peak parasitemia levels, and day of 100% group mortality varied among 
the groups receiving sera, a Tukey's pairwise comparison test showed no significant difference at 
the 0.05 level in peak parasitemia level or peak day among any of the treatment and control 
groups (see Fig. 4). Among all treatment groups receiving whole spleen cells there was no 
significant difference in the day peak parasitemia occurred (F 7 32 = 1.753; P = 0.136). 
However, the peak parasitemia level differed significantly among groups, in particular, the ETI 
spleen group parasitemia levels were significantly lower than all other treatment groups 
according to the HSD criterion (F 7^  32 = 11.764; P = < 0.001). 
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TABLE 1. Summary of parasitemia and mortality data for Phase 1, 2, and 3. RTI refers to room 
temperature infected. RTNI refers to room temperature noninfected. ETI refers to elevated 
temperature infected. ETNI refers to elevated temperature noninfected. 
Mean Peak Day of 100% 
Group Onset Parasitemia Peak day Mortality 
RTI 14.6 715 x 1 0 4 a 33 ***** 
ETI 20 272 x 1 0 4 a 74 ***** 
RTI sera 13 739 x 1 0 4 a 33 47 
RTNI sera 19.8 435 x 1 0 4 a 35 59 
RTI spleen 15 415 x 1 0 4 a 33 55 
RTNI spleen 15.6 136 x 104 a 33 47 
ETI sera 15.4 1680 x 104 a 39 45 
ETNI sera 13 1185 x 104 a 33 35 
ETI spleen 16.6 14 x 1 0 4 b 19 and 33 
ETNI spleen 13 565 x 104 a 29 36 
a = groups demonstrating no statistically significant differences 
b = group demonstrating statistically significant differences 
* = groups euthanised 
- = groups still alive 
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FIGURE 1. Effect of 21°C versus 36°C environmental temperature on parasitemia and course 
of infection with T. cruzi. The mice maintained at room temperature were euthanised on day 35 
of infection. The mice held at elevated temperature were euthanised on day 98 of infection. 
Data are presented as the mean number of parasites per ml of blood, with six mice per group. 
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FIGURE 2. The effect of adoptive or passive transfer on parasitemia levels in Phase 2. The 
average parasitemias in recipients of sera or whole spleen cells from infected mice, as well as 
noninfected controls maintained at 21°C are given. Recipient mice were infected with 103 BFTs 
and held at 21°C. Data are presented as the mean number of parasites per ml of blood, with five 
mice per group. RTI refers to room temperature infected. RTNI refers to room temperature 
noninfected. 
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FIGURE 3. The effect of adoptive or passive transfer on the survival of recipients in Phase 2. 
RTI refers to room temperature infected. RTNI refers to room temperature noninfected. 
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FIGURE 4. The effect of adoptive or passive transfer on parasitemia levels in Phase 3. The 
average parasitemias in recipients of sera or whole spleen cells from infected mice, as well as, 
noninfected controls maintained at 36°C are given. Recipient mice were infected with 1(P BFTs 
and held at 21°C. Data are presented as the mean number of parasites per ml of blood, with five 
mice per group. ETI refers to elevated temperature infected. ETNI refers to elevated temperature 
noninfected. 
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FIGURE 5. The effect of adoptive or passive transfer on the survival of recipients in Phase 3. 
ETI refers to elevated temperature infected. ETNI refers to elevated temperature noninfected. 
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Chapter 4 
Discussion 
The results of this study demonstrate that an elevated environmental temperature of 36°C can 
significantly alter the course of a lethal infection with the Brazil strain of T. cruzi in highly 
susceptible C3HeB/FeJ mice by delaying onset of parasitemia, decreasing peak parasitemia 
levels, prolonging the day peak levels are reached, clearing of BFTs, and increasing longevity. 
This finding has been documented by several other investigators (Anderson and Kuhn, 1989; 
Dimock et al., 1991; Guo, 1994; Ming, 1994; Gao, 1995). Maintenance of T. cruzi-infected mice 
at 36°C has been shown to not only increase survival rate and decrease parasitemia levels but 
also to significantly enhance both parasite-specific and nonspecific immune responses (Anderson 
and Kuhn, 1989; Gao, 1995). However, the immune mechanisms responsible for this enhanced 
immune responsiveness have not been clearly defined. 
The results of the present study demonstrate that the protection observed at elevated 
temperature can be transferred to naive mice by adoptive transfer of whole spleen cells from 
mice that have survived infection at 36°C. The success of adoptive transfer indicates that cell-
mediated immunity is responsible for the enhanced protection. The mice receiving this treatment 
displayed significantly lower parasitemias, rapidly cleared circulating BFTs, and had a 100% 
survival rate in contrast to all other treatment groups that were not statistically different from 
their controls and had a 100% mortality rate. 
In contrast, the results of this study provide no evidence for immune protection imparted 
passively through sera as demonstrated by a course of infection similar to the controls, the 
highest parasitemias, and a 100% mortality. Studies performed by Dimock et al., 1991, also 
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suggest that antibodies do not play a major role in the protection observed at elevated 
temperatures. These antibodies do not play a major role in the protection observed at elevated 
temperatures. These investigators reported no correlation between antibody levels and 
parasitemias or survival. Using ELISA and immunoblot analysis the authors found that anti-75 
cruzi antibodies were initially low in mice maintained at 36°C, but by day 40 post infection the 
parasite specific antibody levels were similar to those seen in mice held at room temperature. 
Furthermore, antibody levels continued to steadily increase throughout infection, peaking at day 
91. These results indicate that antibody levels peak far too late to stop the acute stage of 
infection but may play a role in late infection. The data from the present experiment support this 
conclusion. There were no significant differences observed in peak parasitemia levels or peak 
day between the mice given sera from infected mice and control mice indicating no additional 
protection by antibodies. Passive transfer was not successful and a 100% mortality rate 
occurred. Guhl et al., 1979, postulated that antibodies accounted for the beneficial effects seen at 
elevated temperature based upon the successful transfer of immunity to naive recipients using 
hyper-immune sera. Varying results may be due to usage of various strains of T. cruzi or mice. 
Also, these investigators used daily injections of a large quantity of sera (0.2 ml) which may 
have contributed to the outcome. 
The present results strongly indicate that cellular immune responses play a significant role in 
controlling infection in the early course of disease and that it is this branch of immunity that is 
enhanced at elevated temperatures. The enhanced protection observed at elevated temperature 
can be imparted to naive mice by the adoptive transfer of whole spleen cells from mice that have 
survived infection at 36°C. The recipients of whole spleen cells displayed even lower 
parasitemias and more rapid clearing of parasites than the original donors. Several other 
investigators also have attributed the immune protection seen at elevated environmental 
temperatures to the components of cell-mediated immunity. Direct plaque-forming cell 
responses to sheep red blood cells, as well as the parasite specific responses of T helper cells 
have been shown to be significantly enhanced in T. cruzi infected mice held at 36°C (Anderson 
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and Kuhn, 1989). The in vivo depletion of the T helper cell subset was shown to advance the 
onset of parasitemia approximately four days in mice maintained at either environmental 
temperature (Guo, 1994). In addition, all mice maintained at elevated temperature and depleted 
of T helper cells exhibited 100% mortality. However, this same study demonstrated that 
maintenance of mice at elevated temperatures still exerted some protective effects even after the 
depletion of CD4 + cells. Guo suggested that this effect may be due to either partial cell recovery 
or to other unknown components of the immune system. Such " other " components may include 
cytokines such as IL-1 which has been shown to enhance T cell responses in vitro at elevated 
temperatures (Duff and Durum, 1983) or IL-2 which has been shown to have depressed levels in 
murine spleen cells during the course of natural infection with T. cruzi (Harel-Bellan et al., 1983; 
Tarleton and Kuhn, 1984; Tarleton 1988). IL-2 is critically important in the regulation of a wide 
variety of immune responses (Mosmann et al., 1991), and elevated temperature has been shown 
to be a powerful promoter of IL-2 transcription and synthesis (Gern et al., 1991). Several 
investigators have declared both CD4 + and CD8+ T cells to be involved in the immune response 
to this parasite in several species of murine models (Trischmann, 1983; Tarleton, 1990; Tarleton 
et al., 1992). Ming (1994) demonstrated that the depletion of CD8+ cells can reverse the positive 
effects noted with elevated temperature. Further studies will be required to determine if CD4 + T 
cells or CD8 + T cells (or both) are responsible for the success of adoptive transfer. In addition, 
despite the positive evidence for T cell activity in this phenomenon, the role of macrophages 
cannot be excluded due to the use of whole spleen cells in this study. 
The results of the present study provide strong evidence that cellular immunity is enhanced by 
maintenance of infected mice at an elevated environmental temperature. The adoptive transfer of 
whole spleen cells from mice that have survived a lethal inoculation of T. cruzi by maintenance 
at 36°C to naive, lethally infected recipients maintained at 21°C imparted immunity that allowed 
for very low parasitemias, quick clearing of BFTs from the bloodstream, and a 100% survival 
rate. In contrast, passive transfer of sera resulted in no additional protection over that seen with 
the control mice and even allowed for higher parasitemias than those seen in the controls. 
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In this study, the goal was to attempt to identify which branch of the immune system becomes 
enhanced when mice are maintained at 36°C and are given a lethal infection of the Brazil strain 
of T. cruzi. Previous studies have indicated that the enhanced immunity is an immunological 
phenomenon but have raised questions regarding which aspects of the immune system are 
responsible for the observed protection. The data presented in this thesis unequivocally 
demonstrate that the protection is due to enhanced cellular immunity with little to no early 
contribution by antibodies. 
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